Assessment of Serum Ischemia Modified Albumin Level and Erectile Functions in Individuals with Premature Greying of Hair

    Omar M. E. Abdel‐Salam, Ghada Mohamed Abdel-Khalek, Afaf A Abd El-Ghaffar, Ataa Said
    Image
    Studysummary This study suggests that ischemia-modified albumin may play a role in premature hair graying and vasogenic erectile dysfunction, potentially serving as indicators of susceptibility and severity. Our plain-language summary of this paper — not a Tressless recommendation.
    The study investigates the relationship between serum ischemia-modified albumin (IMA) levels and erectile dysfunction (ED) in individuals with premature hair graying (PGH). The findings suggest that serum IMA may play a role in the onset of premature hair graying and could serve as an independent marker for its severity. Additionally, there were significant differences in ED between those with and without PGH, indicating a potential link between vasculogenic ED and IMA levels. The study also notes that ED may be more prevalent in individuals with polycystic ovary syndrome (PGH).
    Discuss this study in the Community →